GlassScriptPhysician profile
Tarek Hammad
NPI 1912212135
$41,625.74
in general payments reported to CMS, 2019-2025
29 companies · $808 in 2025
The $808 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $21K · 2021: $867 · 2022: $6,566 · 2023: $10K · 2024: $1,127 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,375 · Food and Beverage: $3,478 · Travel and Lodging: $1,310 · Consulting Fee: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,375.00 |
| Food and Beverage | $3,477.90 |
| Travel and Lodging | $1,309.80 |
| Consulting Fee | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,269.75 | 2019-2020 | |
| Medtronic, INC. | $14,464.60 | 2021-2025 | Onyx Frontier, In.Pact Admiral, Endurant Iis |
| Boston Scientific Corporation | $2,879.32 | 2020-2025 | Opticross, Avvigo Guidance System, Eluvia |
| Abbott Laboratories | $1,268.60 | 2019-2024 | Esprit, Jeti All In One Non-Sterile Kit, Dragonfly Opstar |
| Stryker Corporation | $296.96 | 2024-2025 | Actishield, Clottriever Bold Catheter, Artix Mt |
| Abiomed | $252.56 | 2019-2023 | Impella |
| Janssen Pharmaceuticals, INC | $226.34 | 2021-2024 | Xarelto |
| Surmodics, INC. | $186.98 | 2025 | Pounce Thrombectomy, Pounce Xl Thrombectomy, Pounce LP Thrombectomy |
| Penumbra, INC. | $116.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $96.05 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.34 | 2022-2025 | Jardiance, Ofev |
| Esperion Therapeutics, INC. | $73.18 | 2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.77 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $46.89 | 2021-2024 | Eliquis |
| Cordis US Corp. | $41.08 | 2023 | Saber, Mynx Control |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $37.62 | 2022-2023 | Strensiq |
| Pfizer INC. | $28.68 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $25.18 | 2023 | Acthar |
| Genentech USA, INC. | $21.89 | 2023 | Actemra |
| Shockwave Medical, INC | $21.79 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $20.58 | 2019 | |
| Lundbeck LLC | $17.81 | 2019 | |
| Philips North America LLC | $15.78 | 2022 | |
| Novo Nordisk INC | $15.53 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $15.13 | 2022 | |
| Merck Sharp & Dohme LLC | $14.89 | 2021 | |
| Amgen INC. | $14.80 | 2021 | |
| Abbvie INC. | $13.40 | 2022 | |
| Sobi, INC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Hammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.